Cargando…

PD1 is expressed on exhausted T cells as well as virus specific memory CD8+ T cells in the bone marrow of myeloma patients

Characterization of CD8+ T cells in the tumor microenvironment (TME) is important to predict responses to checkpoint therapy. The TME in multiple myeloma is the bone marrow, which also is an immune organ where immune responses are generated and memory cells stored. The presence of T cells with other...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sponaas, Anne-Marit, Yang, Rui, Rustad, Even Holth, Standal, Therese, Thoresen, Aud Solvang, Dao Vo, Camilla, Waage, Anders, Slørdahl, Tobias S., Børset, Magne, Sundan, Anders
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2018
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6112830/ https://www.ncbi.nlm.nih.gov/pubmed/30174794 http://dx.doi.org/10.18632/oncotarget.25882

Ejemplares similares

PDL1 Expression on Plasma and Dendritic Cells in Myeloma Bone Marrow Suggests Benefit of Targeted anti PD1-PDL1 Therapy
por: Sponaas, Anne-Marit, et al.
Publicado: (2015)

Bystander Memory T Cells and IMiD/Checkpoint Therapy in Multiple Myeloma: A Dangerous Tango?
por: Sponaas, Anne Marit, et al.
Publicado: (2021)

Monitoring multiple myeloma by quantification of recurrent mutations in serum
por: Rustad, Even Holth, et al.
Publicado: (2017)

Conversion of ATP to adenosine by CD39 and CD73 in multiple myeloma can be successfully targeted together with adenosine receptor A2A blockade
por: Yang, Rui, et al.
Publicado: (2020)

Erythropoietin (EPO)-receptor signaling induces cell death of primary myeloma cells in vitro
por: Våtsveen, Thea Kristin, et al.
Publicado: (2016)

Identification of the source of elevated hepatocyte growth factor levels in multiple myeloma patients
por: Rampa, Christoph, et al.
Publicado: (2014)

The proportion of CD16(+)CD14(dim) monocytes increases with tumor cell load in bone marrow of patients with multiple myeloma
por: Sponaas, Anne M, et al.
Publicado: (2015)

The serine protease matriptase inhibits migration and proliferation in multiple myeloma cells
por: Steiro, Ida, et al.
Publicado: (2022)

Clonal evolution after treatment pressure in multiple myeloma: heterogenous genomic aberrations and transcriptomic convergence
por: Misund, Kristine, et al.
Publicado: (2022)

MYC amplifications in myeloma cell lines: correlation with MYC-inhibitor efficacy
por: Holien, Toril, et al.
Publicado: (2015)

Correction: MYC amplifications in myeloma cell lines: correlation with MYC-inhibitor efficacy
por: Holien, Toril, et al.
Publicado: (2018)

Targeting phosphoglycerate dehydrogenase in multiple myeloma
por: Elsaadi, Samah, et al.
Publicado: (2021)

c-Met signaling promotes IL-6-induced myeloma cell proliferation
por: Hov, Håkon, et al.
Publicado: (2009)

Caspase‐8 regulates the expression of pro‐ and anti‐inflammatory cytokines in human bone marrow‐derived mesenchymal stromal cells
por: Moen, Siv H., et al.
Publicado: (2016)

The phosphatase of regenerating liver-3 (PRL-3) is important for IL-6-mediated survival of myeloma cells
por: Slørdahl, Tobias S., et al.
Publicado: (2016)

Paired miRNA- and messenger RNA-sequencing identifies novel miRNA-mRNA interactions in multiple myeloma
por: Aass, Kristin Roseth, et al.
Publicado: (2022)

High expression of BCL3 in human myeloma cells is associated with increased proliferation and inferior prognosis
por: Brenne, Anne-Tove, et al.
Publicado: (2009)

Ectonucleotidase CD39 and Checkpoint Signalling Receptor Programmed Death 1 are Highly Elevated in Intratumoral Immune Cells in Non–small-cell Lung Cancer
por: Tøndell, Anders, et al.
Publicado: (2019)

Comprehensive small RNA-sequencing of primary myeloma cells identifies miR-105-5p as a predictor of patient survival
por: Roseth Aass, Kristin, et al.
Publicado: (2022)

Intracellular IL-32 regulates mitochondrial metabolism, proliferation, and differentiation of malignant plasma cells
por: Aass, Kristin Roseth, et al.
Publicado: (2021)

Bone Morphogenetic Protein 4 Gene Therapy in Mice Inhibits Myeloma Tumor Growth, But Has a Negative Impact on Bone
por: Westhrin, Marita, et al.
Publicado: (2019)

Highly expressed genes in multiple myeloma cells – what can they tell us about the disease?
por: Børset, Magne, et al.
Publicado: (2022)

Elevated serum concentrations of activated hepatocyte growth factor activator in patients with multiple myeloma
por: Wader, K F, et al.
Publicado: (2008)

Intracellular glutathione determines bortezomib cytotoxicity in multiple myeloma cells
por: Starheim, K K, et al.
Publicado: (2016)

Chemerin is elevated in multiple myeloma patients and is expressed by stromal cells and pre-adipocytes
por: Westhrin, Marita, et al.
Publicado: (2018)

Hydroxychloroquine potentiates carfilzomib toxicity towards myeloma cells
por: Baranowska, Katarzyna, et al.
Publicado: (2016)

Oncogene addiction to c-MYC in myeloma cells
por: Holien, Toril, et al.
Publicado: (2012)

P950: COMBINED PROTEASOME AND AUTOPHAGY INHIBITION IN RELAPSED/REFRACTORY MULTIPLE MYELOMA – A PHASE I TRIAL OF HYDROXYCHLOROQUINE, CARFILZOMIB AND DEXAMETHASONE
por: Slørdahl, T. S., et al.
Publicado: (2022)

Bone morphogenetic protein-9 suppresses growth of myeloma cells by signaling through ALK2 but is inhibited by endoglin
por: Olsen, O E, et al.
Publicado: (2014)

Expression of phosphatase of regenerating liver (PRL)-3, is independently associated with biochemical failure, clinical failure and death in prostate cancer
por: Andersen, Sigve, et al.
Publicado: (2017)

Potential value of pre-planned imaging of bone disease in multiple myeloma
por: Gundesen, Michael T., et al.
Publicado: (2023)

Phosphatase of regenerating liver-3 is expressed in acute lymphoblastic leukemia and mediates leukemic cell adhesion, migration and drug resistance
por: Hjort, Magnus A., et al.
Publicado: (2017)

Targeting Proliferating Cell Nuclear Antigen and Its Protein Interactions Induces Apoptosis in Multiple Myeloma Cells
por: Müller, Rebekka, et al.
Publicado: (2013)

Cyclic AMP induces apoptosis in multiple myeloma cells and inhibits tumor development in a mouse myeloma model
por: Follin-Arbelet, Virginie, et al.
Publicado: (2011)

BRAF V600E mutation in early-stage multiple myeloma: good response to broad acting drugs and no relation to prognosis
por: Rustad, E H, et al.
Publicado: (2015)

Inhibition of Cytosolic Phospholipase A2α Induces Apoptosis in Multiple Myeloma Cells
por: Mahammad, Nur, et al.
Publicado: (2021)

Phosphatase of regenerating liver 3 (PRL-3) is overexpressed in human prostate cancer tissue and promotes growth and migration
por: Vandsemb, Esten N., et al.
Publicado: (2016)

Risk of multiple myeloma and other malignancies among first‐ and second‐degree relatives of patients with multiple myeloma: A population‐based study
por: Langseth, Øystein O., et al.
Publicado: (2022)

The natural compound forskolin synergizes with dexamethasone to induce cell death in myeloma cells via BIM
por: Follin-Arbelet, Virginie, et al.
Publicado: (2015)

Phosphatase of regenerating liver-3 (PRL-3) is overexpressed in classical Hodgkin lymphoma and promotes survival and migration
por: Hjort, Magnus Aassved, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_a8v9auqkovbdf9ji0n5qsio1cs